Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Salts in Persistent Asthma
NCT00927901Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Jun 2009; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00927901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927901.